Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 232 results.
User Information
Export Records
  1. 1.   Scaffolding viral protein NC nucleates phase separation of the HIV-1 biomolecular condensate
  2. Monette, Anne; Niu, Meijuan; Nijhoff Asser, Maya; Gorelick,Robert; Mouland, Andrew J
  3. Cell Reports. 2022, Aug 23; 40(8): 111251.
  1. 2.   Relative domain orientation of the L289K HIV-1 reverse transcriptase monomer
  2. Xi, Zhaoyong; Ilina, Tatiana V; Guerrero, Michel; Fan,Lixin; Sluis-Cremer, Nicolas; Wang,Yun-Xing; Ishima, Rieko
  3. Protein Science : a publication of the Protein Society. 2022, May; 31(5): e4307.
  1. 3.   Crystal Structure of a Retroviral Polyprotein: Prototype Foamy Virus Protease-Reverse Transcriptase (PR-RT)
  2. Harrison, Jerry Joe E K; Tuske, Steve; Das, Kalyan; Ruiz, Francesc X; Bauman, Joseph D; Boyer,Paul; DeStefano, Jeffrey J; Hughes,Stephen; Arnold, Eddy
  3. Viruses. 2021, Aug; 13(8):
  1. 4.   In-utero exposure to zidovudine-containing antiretroviral therapy and clonal hematopoiesis in HIV-exposed uninfected newborns
  2. Lin, Shu-Hong; Wang, Youjin; Hartley, Stephen W.; Karyadi, Danielle M.; Lee, Olivia W.; Zhu, Bin; Zhou,Weiyin; Brown, Derek W.; Beilstein-Wedel, Erin; Hazra, Rohan; Kacanek, Deborah; Chadwick, Ellen G.; Marsit, Carmen J.; Poirier, Miriam C.; Brummel, Sean S.; Chanock, Stephen J.; Engels, Eric A.; Machiela, Mitchell J.
  3. AIDS. 2021, Aug 1; 35(10): 1525-1535.
  1. 5.   Structure-Based Non-Nucleoside Inhibitor Design: Developing Inhibitors that Are Effective Against Resistant Mutants
  2. Smith,Steven; Pauly,Gary; Hewlett, Katharine; Schneider,Joel; Hughes,Stephen
  3. Chemical biology & drug design. 2020, SEP 17;
  1. 6.   (Q)SAR Models of HIV-1 Protein Inhibition by Drug-Like Compounds
  2. Stolbov, Leonid A; Druzhilovskiy, Dmitry S; Filimonov, Dmitry A; Nicklaus,Marc; Poroikov, Vladimir V
  3. Molecules (Basel, Switzerland). 2020, Jan 1; 25(1):
  1. 7.   Linked dual-class HIV resistance mutations are associated with treatment failure
  2. Boltz,Valerie; Shao,Wei; Bale,Michael; Halvas, Elias; Luke,Brian; McIntyre, James A.; Schooley, Robert T.; Lockman, Shahin; Currier, Judith S.; Sawe, Fred; Hogg, Evelyn; Hughes, Michael D.; Kearney,Mary; Coffin, John M.; Mellors, John W.
  3. JCI INSIGHT. 2019, OCT 3; 4(19):
  1. 8.   Heterogeneous antiretroviral drug distribution and HIV/SHIV detection in the gut of three species
  2. Thompson, Corbin G; Rosen, Elias P; Prince, Heather M A; White, Nicole; Sykes, Craig; de la Cruz, Gabriela; Mathews, Michelle; Deleage,Claire; Estes,Jake; Charlins, Paige; Mulder, Leila R; Kovarova, Martina; Adamson, Lourdes; Arora, Shifali; Dellon, Evan S; Peery, Anne F; Shaheen, Nicholas J; Gay, Cynthia; Muddiman, David C; Akkina, Ramesh; Victor Garcia, J; Luciw, Paul; Kashuba, Angela D M
  3. Science translational medicine. 2019, Jul 03; 11(499): pii: eaap8758..
  1. 9.   Reverse Transcription in the Saccharomyces cerevisiae Long-Terminal Repeat Retrotransposon Ty3
  2. Rausch, Jason; Miller, Jennifer; Legrice, Stuart
  3. VIRUSES-BASEL. 2017, Mar; 9(3):
  1. 10.   Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins
  2. Ahi, Yadvinder; Zhang, Shu; Thappeta, Yashna; Denman, Audrey; Feizpour, Amin; Gummuluru, Suryaram; Reinhard, Bjoern; Muriaux, Delphine; Fivash, Matt; Rein, Alan
  3. MBIO. 2016, Nov 22; 7(6): e01985.
  1. 11.   A Triazinone Derivative Inhibits HIV-1 Replication by Interfering with Reverse Transcriptase Activity
  2. Urano, E.; Miyauchi, K.; Kojima, Y.; Hamatake, M.; Ablan, S. D.; Fudo, S.; Freed, E. O.; Hoshino, T.; Komano, J.
  3. Chemmedchem. 2016, 19-Oct; 11(20): 2320-2326.
  1. 12.   Localization of ASV Integrase-DNA Contacts by Site-Directed Crosslinking and their Structural Analysis
  2. Peletskaya, E.; Andrake, M.; Gustchina, A.; Merkel, G.; Alexandratos, J.; Zhou, D. W.; Bojja, R. S.; Satoh, T.; Potapov, M.; Kogon, A.; Potapov, V.; Wlodawer, A.; Skalka, A. M.
  3. Plos One. 2011, Dec; 6(12):
  1. 13.   Genotypic Resistance at Viral Rebound Among Patients Who Received Lopinavir/Ritonavir-Based or Efavirenz-Based First Antiretroviral Therapy in South Africa
  2. Dlamini, J. N.; Hu, Z. H.; Ledwaba, J.; Morris, L.; Maldarelli, F. M.; Dewar, R. L.; Highbarger, H. C.; Somaroo, H.; Sangweni, P.; Follmann, D. A.; Pau, A. K.; Phidisa, I. I. S. T.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2011, Nov; 58(3): 304-308.
  1. 14.   The effects of RNase H inhibitors and nevirapine on the susceptibility of HIV-1 to AZT and 3TC
  2. Davis, C. A.; Parniak, M. A.; Hughes, S. H.
  3. Virology. 2011, Oct; 419(2): 64-71.
  1. 15.   An evaluation of the RNase H inhibitory effects of Vietnamese medicinal plant extracts and natural compounds
  2. Tai, B. H.; Nhut, N. D.; Nhiem, N. X.; Quang, T. H.; Nguyen, T. T. N.; Bui, T. T. L.; Huong, T. T.; Wilson, J.; Beutler, J. A.; Ban, N. K.; Cuong, N. M.; Kim, Y. H.
  3. Pharmaceutical Biology. 2011, Oct; 49(10): 1046-1051.
  1. 16.   Mechanisms and Factors that Influence High Frequency Retroviral Recombination
  2. Delviks-Frankenberry, K.; Galli, A.; Nikolaitchik, O.; Mens, H.; Pathak, V. K.; Hu, W. S.
  3. Viruses-Basel. 2011, Sep; 3(9): 1650-1680.
  1. 17.   Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaques
  2. Kulkarni, V.; Jalah, R.; Ganneru, B.; Bergamaschi, C.; Alicea, C.; von Gegerfelt, A.; Patel, V.; Zhang, G. M.; Chowdhury, B.; Broderick, K. E.; Sardesai, N. Y.; Valentin, A.; Rosati, M.; Felber, B. K.; Pavlakis, G. N.
  3. Vaccine. 2011, Sep; 29(39): 6742-6754.
  1. 18.   Majority of CD4(+) T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule
  2. Josefsson, L.; King, M. S.; Makitalo, B.; Brannstrom, J.; Shao, W.; Maldarelli, F.; Kearney, M. F.; Hu, W. S.; Chen, J. B.; Gaines, H.; Mellors, J. W.; Albert, J.; Coffin, J. M.; Palmer, S. E.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2011, Jul; 108(27): 11199-11204.
  1. 19.   Inhibition of multi-drug resistant HIV-1 reverse transcriptase by nucleoside beta-triphosphates
  2. Dash, C.; Ahmadibeni, Y.; Hanley, M. J.; Pandhare, J.; Gotte, M.; Le Grice, S. F. J.; Parang, K.
  3. Bioorganic & Medicinal Chemistry Letters. 2011, Jun; 21(12): 3519-3522.
  1. 20.   Anti-HIV microbicide development: targeting the virus is the key
  2. O'Keefe, B. R.
  3. Future Virology. 2011, May; 6(5): 553-556.
  1. 21.   4 '-C-Methyl-2 '-Deoxyadenosine and 4 '-C-Ethyl-2 '-Deoxyadenosine Inhibit HIV-1 Replication
  2. Vu, B. C.; Boyer, P. L.; Siddiqui, M. A.; Marquez, V. E.; Hughes, S. H.
  3. Antimicrobial Agents and Chemotherapy. 2011, May; 55(5): 2379-2389.
  1. 22.   Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine
  2. Boltz, V. F.; Zheng, Y.; Lockman, S.; Hong, F. Y.; Halvas, E. K.; McIntyre, J.; Currier, J. S.; Chibowa, M. C.; Kanyama, C.; Nair, A.; Owino-Ong'or, W.; Hughes, M.; Coffin, J. M.; Mellors, J. W.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2011, May; 108(22): 9202-9207.
  1. 23.   Phenotypic characterization of drug resistance-associated mutations in HIV-1 RT connection and RNase H domains and their correlation with thymidine analogue mutations
  2. Lengruber, R. B.; Delviks-Frankenberry, K. A.; Nikolenko, G. N.; Baumann, J.; Santos, A. F.; Pathak, V. K.; Soares, M. A.
  3. Journal of Antimicrobial Chemotherapy. 2011, Apr; 66(4): 702-708.
  1. 24.   Telomerase and primary T cells: biology and immortalization for adoptive immunotherapy
  2. Barsov, E. V.
  3. Immunotherapy. 2011, Mar; 3(3): 407-421.
  1. 25.   Mechanisms of HIV-1 drug resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors
  2. Nikolenko, G. N.; Kotelkin, A. T.; Oreshkova, S. F.; Ilyichev, A. A.
  3. Molecular Biology. 2011, Feb; 45(1): 93-109.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel